FDA NDC Directory · JSON-LD · Markdown

LANSOPRAZOLE

NDC 70771-1133 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Labeler / ManufacturerZydus Lifesciences Limited
Marketing categoryAbbreviated NDA (generic) · App ANDA200816
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsLANSOPRAZOLE (30 mg/1)
Marketing started20181130
Package count1

External sources

Source: openFDA. Public-domain (CC0).